Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.540
+0.010 (1.89%)
At close: Mar 9, 2026, 4:00 PM EDT
0.547
+0.007 (1.30%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Xilio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 40 | 42 | 15 | 74 | 437 | - | |
| Market Cap Growth | -14.87% | 177.26% | -79.46% | -83.14% | - | - | |
| Enterprise Value | -57 | -11 | -30 | -45 | 581 | - | |
| Last Close Price | 0.54 | 0.95 | 0.55 | 2.69 | 16.00 | - | |
| PS Ratio | 1.25 | 6.62 | - | - | - | - | |
| PB Ratio | - | 2.38 | 0.41 | 0.70 | 2.36 | - | |
| P/TBV Ratio | - | 2.38 | 0.41 | 0.70 | 2.36 | - | |
| Debt / Equity Ratio | -0.90 | 0.46 | 0.34 | 0.19 | 0.11 | -4.14 | |
| Net Debt / Equity Ratio | 11.92 | -2.68 | -0.87 | -0.95 | -0.96 | -0.50 | |
| Net Debt / EBITDA Ratio | 2.29 | 0.81 | 0.42 | 1.15 | 2.41 | -0.05 | |
| Net Debt / FCF Ratio | 5.49 | 2.56 | 0.47 | 1.29 | 2.17 | -0.07 | |
| Asset Turnover | 0.31 | 0.10 | - | - | - | - | |
| Quick Ratio | 2.15 | 2.10 | 2.80 | 5.70 | 15.50 | 0.87 | |
| Current Ratio | 2.20 | 2.21 | 3.02 | 5.90 | 15.85 | 0.93 | |
| Return on Equity (ROE) | -908.29% | -214.02% | -107.25% | -60.62% | -84.16% | -332.22% | |
| Return on Assets (ROA) | -26.26% | -56.48% | -49.44% | -31.20% | -36.88% | -68.86% | |
| Return on Capital Employed (ROCE) | -56.60% | -136.10% | -176.00% | -75.50% | -36.60% | -385.30% | |
| Earnings Yield | -147.45% | -138.74% | -504.62% | -119.66% | -17.33% | - | |
| FCF Yield | -44.32% | -43.86% | -456.42% | -105.24% | -18.72% | - | |
| Buyback Yield / Dilution | -17.23% | -94.62% | -0.38% | -388.59% | -970.34% | -27.97% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.